entertainment -WSS

entertainment

author：entertainment 2025-09-29 00:38:34 - browse：3

After physically debilitating cancer treatment, Laurie Brunner encountered another medical hurdle: She had developed lymphedema that required surgery, but her BMI was over the cutoff. To receive the necessary treatment, she would have to lose weight.

“But after everything I’ve been through, my body was just not having it,” she said. So she turned to Jody Dushay, an endocrinologist at the Beth Israel Deaconess Medical Center and assistant professor of medicine at Harvard Medical School. After much discussion, the two decided that Laurie should try using weight loss medication — specifically, Wegovy — so she could become eligible for the surgery.

Before long, they had to grapple with the shortage of GLP-1 medications. “Within the first two months she had a good response,” Jody said. But “then there was the first round of shortages. … It looks like, you know, we’re heading towards that finish line. And then, ‘Oh, sorry, you can’t get it anymore.’”

On the “First Opinion Podcast,” I spoke with Jody and Laurie about how the ongoing shortages of GLP-1 medications are creating logistical and medical problems. Our conversation was based on Jody’s recent First Opinion essay, “How the Wegovy shortage is making life impossible for my patients — and for me.” We talked about the patient and provider perspective, the way stigma affects access to care, the ways weight loss medications are changing the medical system, and how the drug shortage is only part of the problem of access.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： European regulators consider appeal over Amylyx ALS drug

entertainment

WSS

New research casts further doubt on a common procedure used with IVF

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

How clinical AI models' predictive power can degrade over time

Bulgari apologizes to China for listing Taiwan as a country after online backlash

What to know about OceanGate, the company behind the missing Titanic submersible

Life sciences deals on track to hit lowest point since 2017

knowledge

entertainment

leisure time

In Memoriam: Notable people who died in 2023

Kidney disease boosts cardiac arrest risk for Hispanics, Latinos

Tori Bowie and the unacceptable rates of Black maternal death

HCA discloses massive data breach affecting 11 million patients

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Alkermes shareholders re

How clinical AI models' predictive power can degrade over time

Hollywood unions extend contract negotiations for actors

New research casts further doubt on a common procedure used with IVF

focus

California’s proposed $25 per hour health care minimum wage

Better Therapeutics data on benefit with GLP

Why 40% Americans with Parkinson’s don’t see a neurologist

Leqembi, other new Alzheimer’s drugs require better biomarkers

Medicare to cover more brain scans related to Alzheimer’s drugs

Retired US general questions alleged Putin, Prigozhin meeting

entertainment

entertainment

hotspot

focus